Successful treatment of thrombotic thrombocytopenic purpura with vincristine report of one case;Púrpura trombocitopénico trombótico con respuesta exitosa a vincristina

Revista Medica de Chile

Volumn 135, Issue 12, 2007, Pages 1572-1576

  Espinoza, Francisco ^a   Leal Fernández, José Luis ^a,c   Arenas, Guillermo ^b  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b Hospital Parroquial de San Bernardo   (Chile)

^c NONE   (Chile)

Author keywords

Purpura, thrombocytopenic; Purpura, thrombotic thrombocytopenic; Vincristine

Indexed keywords

FIBRINOLYTIC AGENT; VINCRISTINE;

ADULT; ARTICLE; BLOOD; CASE REPORT; HUMAN; MALE; PLASMAPHERESIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; FIBRINOLYTIC AGENTS; HUMANS; MALE; PLASMAPHERESIS; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VINCRISTINE;

EID: 40549097769     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. MOSCHCOWITZ E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 1924; 24: 21.
2. BURTON R, JAMES G. Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults. Up To Date 14.2.2006.
3. ADLER S, NAST C. Thrombotic Microangiopathies. En: Greenberg A. Primer on Kidney diseases. Philadelphia: Elsevier Saunders, 2005; 265-72.
4. MITRA D, JAFFE EA, WESKLER B ET AL. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997; 89:1224.
5. MOAKE JL. Thrombotic Microangiopathies. N Engl J Med 2002; 347: 589-98.
6. KELLY F, TREACHER D, WILLIAMS F, HUNT B, HOWARD R. Coma in thrombotic thrombocytopenic purpura J Neurol Neurosurg Psychiatry 1999; 66: 688-97.
7. BLUM AS, DRISLANE FW. Nonconvulsive status epilepticus in thrombotic thrombocytopenic purpura. Neurology 1996: 47: 1079-81.
8. HANDLIN RI. Trastornos de las plaquetas y de la pared vascular. En Harrison's Principles of Internal Medicine, Kasper et al. 16th Edition 2005.
9. GUTTERMAN LA, STEVENSON TD. Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA 1982; 247: 1433-6.
10. SADLER JE, MOAKE JL, MIYATA T, GEORGE JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004: 407-23.
11. AQUI NA, STEIN SH, KONKLE BA, ABRAMS CS, STROBL FJ. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apher 2003; 18: 51-4.
12. KAPPERS-KLUNNE MC, WIJERMANS P, FIJNHEER R, CROOCKEWIT AJ, VAN DER HOLT B, DE WOLF JT ET AL. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2005; 130: 768-76.
13. OUTSCHOORN UM, FERBER A. Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: a retrospective cohort study. Am J Hematol 2006; 81: 895-900.
14. FERRARA F, COPIA C, ANNUNZIATA M, SPASIANO A, DI GRAZIA C, PALMIERI C ET AL. Vincristine as salvage treatment for refractary thrombotic thrombocytopenic purpura. Ann Hematol 1999; 78: 521-3.
15. CHAMOUNI P, LENAIN P, BUCHONNET G, MERLE B, BOURGAIN C, BOYER A ET AL. Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine. Transfus Sci 2000; 23: 101-6.
16. ZIMAN A, MITRI M, KLAPPER E, PEPKOWITZ SH, GOLDFINGER D. Combination Vincristine and plasma exchange as inicial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of literature. Transfusion 2005; 45: 41-9.
17. BOHMM M, BETZ C, MIESBACH W, KRAUSE M, VON AUER C, GEIGER H, SCHARRER I. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol 2005; 129: 644-52.
18. NISHIO K, ANDERSON PJ, ZHENG XL, SADLER JE. Binding of platelet glycoprotein Ibα to Von Willebrand factor domain A-1 estimulates the cleavage of the adjacent domain A-2 by ADAMTS 13. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 10578-83.